Murphy Rinki, Thornley Simon, de Zoysa Janak, Stamp Lisa K, Dalbeth Nicola, Merriman Tony R
Department of Medicine, Faculty of Medical and Health Sciences, University of Auckland, Auckland, New Zealand; Maurice Wilkins Centre for Biodiscovery, Auckland, New Zealand.
Population Health Directorate, Counties Manukau District Health Board, Auckland, New Zealand.
PLoS One. 2015 May 15;10(5):e0125543. doi: 10.1371/journal.pone.0125543. eCollection 2015.
Current guidelines for the management of type 2 diabetes and gout recommend that people with these conditions limit their sugar sweetened beverage (SSB) intake. We examined self-reported SSB intake among New Zealand adults with gout or type 2 diabetes, including those on hemodialysis.
1023 adults with gout and 580 adults (including 206 receiving hemodialysis) with type 2 diabetes, participated in this study of between 2009 and 2012. Participants completed an interviewer-administered SSB intake question "how many sugar sweetened drinks (including fruit juice), but not including diet drinks, do you normally drink per day?" SSB consumption was recorded as a circled number 0, 1, 2, 3, 4, 5, or >5, cans or large glasses (300 mL) per day.
Consuming one or more SSB per day was reported by 64% (622/1023) of subjects with gout, 49% (176/374) with type 2 diabetes without dialysis, and 47% (96/206) with diabetes on dialysis. Consuming four or more SSBs per day was reported by 18% (179/1023), 9% (31/374) and 9% (18/206), respectively. Such high consumers of SSB were characterized after multivariable analysis to be more likely to be male (adjusted odds ratio (OR) 1.8; 95% confidence interval 1.1-2.9), younger in age (40 vs 65 years: 1.6; 1.1-2.3), current smoker (5.2; 2.7-10.1), obese (BMI 41 vs 26 kg/m(2): 1.4; 1-1.9), and report Māori (1.8; 1.2-2.8) or Pacific (1.6; 1.1-2.5) ancestry, compared to Caucasian. People with gout were more likely to report heavy SSB intake compared to people with diabetes (OR 2.4, 95% CI 1.5-3.9). Heavy SSB consumption reported by people with diabetes was similar if they did or did not require dialysis.
A high proportion of patients with gout and type 2 diabetes, including those on haemodialysis, are not responding to health messages to abstain from SSB consumption.
2型糖尿病和痛风的现行管理指南建议患有这些疾病的人限制其含糖饮料（SSB）的摄入量。我们调查了新西兰患有痛风或2型糖尿病的成年人（包括接受血液透析的患者）自我报告的SSB摄入量。
1023名痛风成年人和580名2型糖尿病成年人（包括206名接受血液透析的患者）在2009年至2012年期间参与了这项研究。参与者完成了一个由访谈员管理的关于SSB摄入量的问题：“你通常每天喝多少杯含糖饮料（包括果汁），但不包括无糖饮料？”SSB的消费量记录为每天0、1、2、3、4、5或>5罐或大杯（300毫升）的圈选数字。
痛风患者中64%（622/1023）报告每天饮用一杯或更多的SSB，未接受透析的2型糖尿病患者中49%（176/374），接受透析的糖尿病患者中47%（96/206）。每天饮用四杯或更多SSB的比例分别为18%（179/1023）、9%（31/374）和9%（18/206）。多变量分析显示，这些高SSB消费者的特征更可能是男性（调整后的优势比（OR）1.8；95%置信区间1.1 - 2.9）、年龄较小（40岁对65岁：1.6；1.1 - 2.3）、当前吸烟者（5.2；2.7 - 10.1）、肥胖（BMI 41对26 kg/m²：1.4；1 - 1.9），并且与白种人相比，报告有毛利人（1.8；1.2 - 2.8）或太平洋岛民（1.6；1.1 - 2.5）血统。与糖尿病患者相比，痛风患者更有可能报告大量饮用SSB（OR 2.4，95% CI 1.5 - 3.9）。糖尿病患者中报告大量饮用SSB的情况，无论是否需要透析都相似。
很大一部分痛风和2型糖尿病患者，包括那些接受血液透析的患者，没有对避免饮用SSB的健康信息做出反应。
